Results
1 -
9 of
9Pryde D. C., Swain N. A., Stupple P. A., West C. W., Marron B., Markworth C. J., Printzenhoff D., Lin Z., Cox P. J., Suzuki R., McMurray S., Waldron G. J., Payne C. E., Warmus J. S., Chapman M. L..
The discovery of a potent Nav1.3 inhibitor with good oral pharmacokinetics, Med. Chem. Commun., 2017 Pressor Response to Oral Tyramine and Monoamine Oxidase Inhibition During Treatment with Ralfinamide (NW-1029), Neurotoxicity Research Voltage-gated sodium channel blockers, 2001-2006: An overview, Medicinal Chemistry Research Ralfinamide realises results in neuropathic pain trial, Inpharma Weekly Ralfinamide efficacious, well tolerated for neuropathic pain, Inpharma Weekly Ralfinamide improves neuropathic pain, Inpharma Weekly